Genflora - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 394,456 | 383,923 | 386,366 | 440,272 | 782,878 | 885,599 | 1,017,800 | 972,709 |
| Profit before tax | 28,102 | 5,311 | 10,193 | 12,585 | 67,454 | 74,657 | 48,509 | 23,554 |
| Net profit | 23,887 | 4,514 | 8,665 | 10,697 | 57,388 | 63,458 | 40,921 | 19,833 |
| Equity | 131,975 | 136,489 | 145,154 | 155,851 | 213,239 | 276,697 | 300,256 | 320,089 |
| Liabilities | 22,490 | 71,641 | 93,952 | 91,932 | 45,352 | 85,143 | 130,924 | 106,166 |
| Non-current assets | 65,657 | 87,128 | 127,235 | 101,798 | 100,929 | 289,452 | 282,465 | 275,345 |
| Current assets | 88,808 | 121,002 | 111,871 | 145,985 | 157,662 | 72,388 | 148,715 | 150,910 |
| Total assets | 154,465 | 208,130 | 239,106 | 247,783 | 258,591 | 361,840 | 431,180 | 426,255 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 175,246 | 162,243 | 121,389 |
| Social insurance contributions | - | - | - | - | - | 36,164 | 44,597 | 48,775 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.1% | -2.7% | +0.6% | +14.0% | +77.8% | +13.1% | +14.9% | -4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 15.5% | 2.2% | 3.6% | 4.3% | 22.2% | 17.5% | 9.5% | 4.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 18.1% | 3.3% | 6.0% | 6.9% | 26.9% | 22.9% | 13.6% | 6.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.1% | 1.2% | 2.2% | 2.4% | 7.3% | 7.2% | 4.0% | 2.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.1% | 1.4% | 2.6% | 2.9% | 8.6% | 8.4% | 4.8% | 2.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.5 | 0.6 | 0.6 | 0.2 | 0.3 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 25,866 | 28,092 | 32,197 | 38,285 | 59,459 | 66,420 | 68,616 | 60,794 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Genflora - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-16 | 2025-10-05 | 3.83 |
| 2025-07-16 | 2025-07-20 | 0.29 |
| 2025-02-18 | 2025-03-16 | 0.56 |
| 2024-02-19 | 2024-03-03 | 1.49 |
| 2023-08-17 | 2023-08-20 | 6.03 |
| 2023-07-28 | 2023-08-02 | 5.72 |
| 2023-07-24 | 2023-07-25 | 5.72 |
| 2023-04-18 | 2023-04-26 | 2009.02 |
| 2022-04-28 | 2022-05-03 | 0.13 |
| 2022-02-17 | 2022-02-20 | 1590.24 |
Genflora - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-20 | 2026-03-27 | 5.96 |
| 2026-03-19 | 2026-03-19 | 0.56 |
| 2026-03-11 | 2026-03-17 | 401.1 |
| 2025-08-27 | 2025-09-08 | 17.28 |
| 2025-07-28 | 2025-07-31 | 10.51 |
| 2025-07-15 | 2025-07-27 | 10.75 |
| 2025-06-28 | 2025-07-14 | 0.4 |
| 2025-06-17 | 2025-06-25 | 9.8 |
| 2025-05-17 | 2025-05-24 | 3.06 |
| 2025-04-28 | 2025-05-01 | 0.97 |
| 2025-04-14 | 2025-04-14 | 2575.74 |
| 2025-01-27 | 2025-01-27 | 2047.62 |
| 2025-01-24 | 2025-01-26 | 2034.42 |
| 2024-11-17 | 2024-11-17 | 2444.78 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Genflora, UAB (code 300589480) is a private limited liability company engaged in flower production. In 2025, the company generated EUR 972.7K in revenue and EUR 19.8K in net profit, corresponding to a 2.0% profit margin. Revenue declined by 4.4% year on year, while the 2-year comparison still shows a 9.8% increase versus 2023. Profitability softened from EUR 63.5K in 2023 to EUR 40.9K in 2024 and EUR 19.8K in 2025, alongside a margin decrease from 7.2% to 4.0% and then 2.0%. Total assets at year-end 2025 were EUR 426.3K, supported by EUR 320.1K in equity and EUR 106.2K in liabilities. The balance sheet remained equity-heavy, with an equity ratio of 75.1% and debt-to-equity of 0.33. Asset turnover stood at 2.28x, ROE at 6.2%, and ROA at 4.7%. Revenue per employee was EUR 60.8K, indicating moderate productivity.